Second video in our series about pain management during the coronavirus (COVID-19) pandemic
Ainsworth Institute Joins New Clinical Trial on Complex Regional Pain Syndrome (CRPS)
The Ainsworth Institute is proud to announce is has joined the CREATE-1 Study: CRPS Treatment Evaluation 1 Study – sponsored by Axsome Therapeutics, Inc. This is an FDA approved trial studying the effects of a new groundbreaking oral medication to treat CRPS. Enrollment will start shortly.
Latest posts by Corey Hunter, M.D. (see all)
- Hydrodissection – Science or Science Fiction - March 23, 2021
- Facebook Live 2 – Full Video - April 2, 2020
- (Full Presentation) Top 5 Things Pain Patients Need To Know During The Coronavirus Pandemic - March 30, 2020